Siddharth Mahure, MD
Orthopaedic Surgery · Montclair, NJNPI 1346696499
Payments from drug & device makers
What this record shows
This record is dominated by education: $15,216 of the $18,151 with a category attached, or 83.8%. 10 manufacturers reported payments, led by Smith+Nephew at 56.8% of the total. Reporting peaked in 2022 at $10,683 and has fallen 95.2% since, to $517 in 2025.
Across 57 payments — averaging $318.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$10K
- Zimmer Biomet$6K
- Globus Medical$967
- Ferring Pharmaceuticals Inc.$258
- Microport Orthopedics Inc$125
- Stryker$98
- plus $94 from 4 others
What the payments were for
- Travel & lodging$1,6879%
- Food & beverage$1,2487%
- Education$15,21684%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 6 | $10,302 |
| Zimmer Biomet | 23 | $6,306 |
| Globus Medical | 4 | $967 |
| Ferring Pharmaceuticals Inc. | 15 | $258 |
| Microport Orthopedics Inc | 1 | $125 |
| Stryker | 3 | $98 |
| Johnson & Johnson(2 entities) | 2 | $35 |
| Seapearl East, Inc | 1 | $21 |
| Sanara Medtech Inc. | 1 | $20 |
| Bioventus LLC | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Persona$4,818
- Avenir$655
- REAL INTELLIGENCE$162
- Journey II$162
- MPO Hip System$125
How this compares
$18,151 in reported general payments places this provider in the 75th percentile of 587 orthopaedic surgery providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 410 | $1,238 |
| Methylprednisolone | 37 | $246 |
| Naproxen | 29 | $210 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Montclair
- Michael KellyHackensack$9.7M
- Mark HartzbandParamus$9.4M
- Randal BetzLawrenceville$3M
- Luke AustinSewell$2.9M
- Kenneth MontgomeryMorristown$2.7M
- Zachary PostEgg Harbor Township$1.7M
- Harlan LevineMontvale$1.5M
- Jeffrey AbramsPrinceton$1.5M
- Gregg KleinParamus$1.5M
- David NazarianMarlton$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.